{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T13:29:04Z","timestamp":1771939744037,"version":"3.50.1"},"reference-count":14,"publisher":"Baishideng Publishing Group Inc.","issue":"20","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2017]]},"DOI":"10.3748\/wjg.v23.i20.3569","type":"journal-article","created":{"date-parts":[[2017,5,27]],"date-time":"2017-05-27T00:13:46Z","timestamp":1495844026000},"page":"3569","source":"Crossref","is-referenced-by-count":31,"title":["Hepatitis C in injection drug users: It is time to treat"],"prefix":"10.3748","volume":"23","author":[{"given":"Alberto","family":"Grassi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgio","family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2060","reference":[{"key":"ref1","unstructured":"Manns MP, McHutchison JG, Gordon SC, Rustgi VK, Shiffman M, Reindollar R, Goodman ZD, Koury K, Ling M, Albrecht JK. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001;358:958-965."},{"key":"ref2","unstructured":"Fried MW, Shiffman ML, Reddy KR, Smith C, Marinos G, Gon\u00e7ales FL, H\u00e4ussinger D, Diago M, Carosi G, Dhumeaux D. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002;347:975-982."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2008.08.009"},{"key":"ref4","unstructured":"Malta M, Magnanini MM, Strathdee SA, Bastos FI. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav 2010;14:731-747."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit306"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2009.09.015"},{"key":"ref7","unstructured":"Broers B, Helbling B, Fran\u00e7ois A, Schmid P, Chuard C, Hadengue A, Negro F. Barriers to interferon-alpha therapy are higher in intravenous drug users than in other patients with acute hepatitis C. J Hepatol 2005;42:323-328."},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis1007"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24656"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2015.06.032"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2015.03.025"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2016.1183644"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.119"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.09.001"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v23\/i20\/3569.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T05:51:48Z","timestamp":1505713908000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v23\/i20\/3569.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017]]},"references-count":14,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.v23.i20.3569","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2017]]}}}